ALC:NYSE
Alcon AG
75,26Â US$
arrow_upward
+1,55%(+1,15) 1D
74,34Â US$
arrow_downward
-1,22% (-0,92)todayPara orarit të tregut
Mbyllur: 18 nën, 4:00:03 m.d., GMT-5 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për ALC...
Hap
73,41Â US$
I lartë
75,52Â US$
I ulët
73,34Â US$
Kapitalizimi i tregut
31,34Â mld
Vëllimi mesatar
2,23Â mln
Vëllimi
58,56 mijë
Maksimumi 52-javor
87,64Â US$
Minimumi 52-javor
61,84Â US$
Beta
0,87
Aksionet në qarkullim
480,40Â mln
Numri i punonjësve
25 mijë
Hap
73,41Â US$
I lartë
75,52Â US$
I ulët
73,34Â US$
Kapitalizimi i tregut
31,34Â mld
Vëllimi mesatar
2,23Â mln
Vëllimi
58,56 mijë
Maksimumi 52-javor
87,64Â US$
Minimumi 52-javor
61,84Â US$
Beta
0,87
Aksionet në qarkullim
480,40Â mln
Numri i punonjësve
25 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Zacks
·
1 ditë më parë
What Drove Glaukos Stock's 48% Rally Since the End of September?
Profili
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Rreth Alcon AG
Drejtori ekzekutivDavid J. Endicott
Punonjësit25 mijë
Themeluar më1945
SeliaGjeneva, Kantoni Gjenevë, Zvicër
SektoriHealth Care
IndustriaMedical device
Uebsajtialcon.com